Acute Breathing Treatment for Wheezing
For acute wheezing, immediately administer nebulized beta-agonist bronchodilators (salbutamol 5 mg or terbutaline 10 mg), and add ipratropium bromide 500 μg if the patient shows features of severe disease or has a poor initial response. 1
Initial Assessment and Severity Classification
Before treating, rapidly assess severity using these objective criteria 1:
Severe asthma features:
- Too wheezy/breathless to complete sentences in one breath
- Respiratory rate ≥ 25/min
- Heart rate ≥110/min
- Peak expiratory flow (PEF) ≤ 50% predicted or best
Life-threatening features:
- PEF < 33% predicted
- Silent chest, cyanosis, or feeble respiratory effort
- Bradycardia or hypotension
- Exhaustion, confusion, or coma
First-Line Treatment Algorithm
For Severe Asthma (PEF ≤ 50%)
Step 1: Nebulized beta-agonist (salbutamol 5 mg or terbutaline 10 mg) driven by oxygen whenever possible 1
Step 2: If poor response or life-threatening features present, immediately add ipratropium bromide 500 μg to the nebulized beta-agonist 1
Step 3: Repeat nebulized beta-agonist + ipratropium every 4-6 hours until PEF >75% predicted and PEF diurnal variability <25% 1
For Mild-Moderate Exacerbations (PEF 50-75%)
Use hand-held inhaler with 200-400 μg salbutamol or 500-1000 μg terbutaline 1
Critical Driving Gas Consideration
Important caveat: If the patient has carbon dioxide retention and acidosis (or if blood gases cannot be measured), drive the nebulizer with air, not oxygen to avoid worsening hypercapnia 1. This is particularly relevant in COPD patients presenting with wheezing.
When to Add Combination Therapy
Add ipratropium bromide 500 μg to beta-agonist treatment in these situations 1:
- Initial presentation with severe features
- Poor response to first beta-agonist dose
- More severe COPD exacerbations
The British Thoracic Society guidelines explicitly recommend combined nebulized treatment (beta-agonist with 250-500 μg ipratropium) for severe cases, especially with poor response to either agent alone 1.
Dosing Specifics
Adults:
- Salbutamol: 2.5-5 mg nebulized
- Terbutaline: 5-10 mg nebulized
- Ipratropium: 500 μg nebulized 1
Children:
- Salbutamol: 5 mg or 0.15 mg/kg nebulized
- Terbutaline: 10 mg or 0.3 mg/kg nebulized
- Ipratropium: 250 μg six hourly 1
Common Pitfalls to Avoid
Don't rely on clinical assessment alone - Always measure PEF or FEV₁ to objectively assess severity 1. Failure to recognize severe attacks contributes to asthma deaths.
Don't delay ipratropium in severe cases - Add it immediately rather than waiting to see if beta-agonist alone works 1
Don't use high-flow oxygen in hypercapnic patients - Switch to air-driven nebulizers if CO₂ retention is present or suspected 1
Don't discharge too early - Continue treatments until PEF is stable at >75% predicted with <25% diurnal variability 1
The evidence base for these recommendations comes from Level A evidence for nebulized beta-agonists in acute severe asthma and Level B-C evidence for adding ipratropium in severe or poorly responding cases 1. While more recent reviews 2, 3 confirm these approaches remain standard, the British Thoracic Society guidelines provide the most specific, actionable treatment algorithms.